Moteur de recherche d’entreprises européennes
Financement de l’UE (2 672 562 €) : Le cycle de vie des vésicules extracellulaires dans le cancer de la prostate : de la biogenèse et de la radioguidage à la pertinence fonctionnelle Hor13/08/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Le cycle de vie des vésicules extracellulaires dans le cancer de la prostate : de la biogenèse et de la radioguidage à la pertinence fonctionnelle
The prostate cancer Extracellular Vesicle LifeCycle (proEVLifeCycle) network is an innovative, multidisciplinary training program focused on understanding the biology, biomarker potential and function of extracellular vesicles (EVs) to resolve unmet clinical needs of prostate cancer (PCa). It is within this realm, that we will equip early stage researchers with the knowledge, tools and a creative ethos to be independent scientists, leaders, and drivers of innovation. The lifecycle of EVs is poorly understood and their potential as non-invasive biomarkers and therapy target/agents, a growing area of interest. This research can perfectly be integrated with the high need for novel biomarkers and therapy targets for PCa. Any relief in the burden of this disease will have major impact on the huge socio-economic problems for patients, families, caregivers and society. The ambitious scientific objectives are to unravel the mysteries of EV biogenesis, homing and uptake to explain how vesicles operate in disease processes; their heterogeneity, their molecular complexity, the biological functions they drive, their local and systemic dissemination and how these may be manipulated. Using state-of-the-art, network-wide shared model systems, imaging and profiling tools, and systems biology, the program will enlighten the lifecycle of EVs and identify novel EV biomarkers and PCa therapy targets to address the unmet clinical needs. Our original network of 7 academic and 3 company beneficiaries and 11 partners, provides optimal scientific training, crosssectoral awareness, entrepreneurship skills, communication in the modern age, extensive opportunities for mobility and patient-facing experiences. We herein meet identified EU-skills gaps providing well-rounded and inventive experts primed for influential careers, contributing to patient well-being and economic prosperity within the EU.
| AIT Austrian Institute OF Technology GmbH | 264 207 € |
| Anaxomics Biotech SL | 250 905 € |
| Asociacion Centro de Investigacion CRL en Biociencias | 250 905 € |
| Cardiff University | 303 173 € |
| ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM | 265 620 € |
| Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III | 250 905 € |
| GenomeScan B.V. | 265 620 € |
| Institut National de la Sante et de la Recherche Medicale | 274 802 € |
| TURUN YLIOPISTO | 280 806 € |
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | 265 620 € |
https://cordis.europa.eu/project/id/860303
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.